ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NRC vs OABI // EV/EBITDA & P/E VALUATION

NRC Health (NASDAQ) VS. OmniAb Inc. (NASDAQ) • 15-METRIC TALLY: NRC 8 — OABI 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. OABI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NRC OABI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 21.00% -22.60% +43.60 NRC /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 18.6x — — TIE /valuation <GO>
Free Cash Flow Yield 3.03% -4.87% +7.90 NRC /fcf-yield <GO>
Operating Margin 16.40% -60.00% +76.40 NRC /operating-margins <GO>
Net Profit Margin 8.40% -60.00% +68.40 NRC /net-margins <GO>
Revenue Growth (YoY) -4.00% -29.30% +25.30 NRC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.11% 0.00% +2.11 NRC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.82 12.19 -8.37 OABI /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 NRC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 66.7 58.7 +8.02 NRC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 41.7x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $519.6M $760.4M -$240.8M OABI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NRC REV OABI REV NRC GROSS % OABI GROSS % NRC FCF OABI FCF
FY 2025 $137.4M $18.7M — — $15.7M -$37.0M
FY 2024 $143.1M $26.4M — — $19.2M -$41.5M
FY 2023 $148.6M $34.2M — — $38.1M $2.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
OABI // BETA —